HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

T Kodama Selected Research

Class A Scavenger Receptors

5/2007Class A scavenger receptor (CD204) attenuates hyperoxia-induced lung injury by reducing oxidative stress.
1/2000Protection from lethal gram-positive infection by macrophage scavenger receptor-dependent phagocytosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


T Kodama Research Topics

Disease

31Neoplasms (Cancer)
01/2016 - 01/2000
8Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2007 - 09/2000
8Atherosclerosis
11/2001 - 08/2000
7Infections
01/2017 - 01/2000
7Inflammation (Inflammations)
09/2007 - 01/2000
6Asthma (Bronchial Asthma)
09/2009 - 01/2000
6Lung Neoplasms (Lung Cancer)
03/2003 - 03/2000
5Adenocarcinoma
05/2006 - 03/2000
5Neoplasm Metastasis (Metastasis)
04/2006 - 01/2000
4Necrosis
01/2016 - 02/2000
4Carcinoma (Carcinomatosis)
11/2007 - 01/2001
4Hepatocellular Carcinoma (Hepatoma)
09/2002 - 01/2000
3Small Cell Lung Carcinoma (Small Cell Lung Cancer)
08/2004 - 03/2000
3Lymphoma (Lymphomas)
08/2002 - 08/2000
3Carcinogenesis
09/2001 - 07/2001
3Stomach Neoplasms (Stomach Cancer)
06/2001 - 01/2000
3Bacterial Infections (Bacterial Infection)
01/2001 - 01/2000
2Pathologic Constriction (Stenosis)
09/2008 - 04/2003
2Carotid Stenosis (Carotid Artery Stenosis)
09/2008 - 08/2006
2Colorectal Neoplasms (Colorectal Cancer)
03/2003 - 08/2002
2Pulmonary Eosinophilia (Eosinophilic Pneumonia)
02/2003 - 04/2002
2Eosinophilia
04/2002 - 01/2000
2Breast Neoplasms (Breast Cancer)
09/2001 - 07/2001
2Endometrial Neoplasms (Endometrial Cancer)
09/2001 - 07/2001
2Neutropenia
08/2001 - 09/2000
2Leukopenia
08/2001 - 03/2001
2Ischemia
08/2001 - 07/2001
2Shock
10/2000 - 04/2000
2Fever (Fevers)
09/2000 - 07/2000
1Leukoencephalopathies
01/2020
1Anorexia
06/2017
1Acute Kidney Injury (Acute Renal Failure)
01/2017
1Intestinal Failure
01/2017
1Anemia
11/2012
1Hematologic Neoplasms (Hematological Malignancy)
11/2012
1Thrombocytopenia (Thrombopenia)
11/2012
1Human Influenza (Influenza)
09/2009
1AIDS-Related Complex (ARC)
09/2008
1Allergic Rhinitis
05/2008
1Prostatic Neoplasms (Prostate Cancer)
04/2008

Drug/Important Bio-Agent (IBA)

11Proteins (Proteins, Gene)FDA Link
11/2012 - 02/2000
10Scavenger Receptors (Scavenger Receptor)IBA
05/2007 - 01/2000
9Cisplatin (Platino)FDA LinkGeneric
08/2004 - 08/2000
4LipopolysaccharidesIBA
06/2017 - 01/2000
4Pharmaceutical PreparationsIBA
09/2007 - 01/2000
4Interleukin-12 (IL 12)IBA
02/2003 - 02/2000
4CytokinesIBA
02/2003 - 01/2000
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2007 - 01/2000
3Monoclonal AntibodiesIBA
04/2006 - 12/2001
3Paclitaxel (Taxol)FDA LinkGeneric
03/2004 - 03/2001
3LipidsIBA
11/2001 - 08/2000
3oxidized low density lipoproteinIBA
11/2001 - 12/2000
3SteroidsIBA
09/2001 - 01/2000
2Interleukin-8 (Interleukin 8)IBA
06/2017 - 06/2001
2Interleukin-6 (Interleukin 6)IBA
06/2017 - 06/2001
2InterleukinsIBA
06/2017 - 06/2001
2EnzymesIBA
04/2008 - 11/2007
2AndrogensIBA
04/2008 - 01/2000
2Biological ProductsIBA
04/2008 - 11/2000
2Messenger RNA (mRNA)IBA
05/2007 - 01/2000
2Class A Scavenger ReceptorsIBA
05/2007 - 01/2000
2alpha-Fetoproteins (alpha-Fetoprotein)IBA
11/2006 - 06/2006
2MucinsIBA
05/2006 - 07/2000
2Cadherins (E-Cadherin)IBA
04/2006 - 02/2001
2AllergensIBA
10/2005 - 01/2000
2Irinotecan (Camptosar)FDA LinkGeneric
08/2004 - 03/2003
2Etoposide (VP 16)FDA LinkGeneric
08/2004 - 03/2003
2OvalbuminIBA
02/2003 - 04/2002
2Immunoglobulin E (IgE)IBA
04/2002 - 01/2000
2AntigensIBA
04/2002 - 01/2000
2Vinorelbine (Navelbine)FDA LinkGeneric
12/2001 - 09/2000
2Biomarkers (Surrogate Marker)IBA
10/2001 - 09/2001
2Estrogen ReceptorsIBA
09/2001 - 07/2001
2TamoxifenFDA LinkGeneric
09/2001 - 07/2001
2Adenosine Triphosphate (ATP)IBA
08/2001 - 07/2001
2polyanionsIBA
01/2001 - 01/2000
2LDL Lipoproteins (beta Lipoproteins)IBA
12/2000 - 01/2000
2LDL Receptors (LDL Receptor)IBA
12/2000 - 01/2000
2Anti-Bacterial Agents (Antibiotics)IBA
09/2000 - 03/2000
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
05/2000 - 01/2000
2Angiogenesis InhibitorsIBA
04/2000 - 02/2000
1ORALIT (ORS)IBA
01/2020
1ABT-737IBA
11/2012
1Amyloid Precursor Protein Secretases (beta-Secretase)IBA
02/2012
1Antiviral Agents (Antivirals)IBA
09/2009
1Angiopoietin-2IBA
09/2009
1Phenobarbital (Luminal)FDA Link
09/2008
1Leukotriene Antagonists (Leukotriene Receptor Antagonists)IBA
05/2008
1pranlukastIBA
05/2008
1Aldo-Keto Reductase Family 1 Member C3IBA
04/2008

Therapy/Procedure

8Drug Therapy (Chemotherapy)
01/2016 - 03/2000
7Therapeutics
01/2016 - 01/2000
2Stents
08/2006 - 01/2006
2Hepatectomy
05/2005 - 01/2000
2Laparotomy
01/2001 - 01/2001
2Pneumonectomy (Lung Volume Reduction)
01/2001 - 03/2000
2Radiotherapy
09/2000 - 09/2000
1Transplantation
01/2017
1Catheters
01/2017
1Embolic Protection Devices
09/2008